Strata Critical Medical Q4 revenue up 83.5% YoY to $66.8M; raises FY2026 guidance

Strata Critical Medical, Inc.

Q4 2025 revenue $66.8M (+83.5% YoY); logistics revenue up 35.3% to $49.2M.
Full year 2025 revenue $197.1M, Adjusted EBITDA $14.1M, both above guidance high end.
Full year 2025 net loss from continuing ops $20.1M vs $16.1M in 2024.
FY2026 revenue guidance raised to $260-275M; Adjusted EBITDA guidance raised to $29-33M.
Clinical segment (Keystone) contributed $17.6M revenue in Q4; total gross profit $14.4M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.